Study of PT027 vs PT007 in Chinese Adults with Asthma
Part of Immune system & allergy, Lungs & breathing clinical trials.
This study tests a new combination inhaler (budesonide/albuterol) against another asthma inhaler in adults whose asthma is not well controlled on their current medications. It aims to see if the new inhaler can reduce serious asthma attacks and improve symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had asthma for at least 1 year, diagnosed by a doctor.
- You are on a daily asthma maintenance inhaler (like a steroid or combination) for at least 3 months, stable for 4 weeks.
- You have had at least one serious asthma attack (needing oral steroids or hospital visit) in the last year.
- You use a rescue inhaler as needed for asthma symptoms.
- You do not have COPD or another chronic lung disease, and you are not a current or recent smoker (heavy past smoking is excluded).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new inhaler (PT027) against another inhaler (PT007) for teens aged 12 to 17 with asthma. It looks at how well the new inhaler works when used as needed, and if it is safe.
This study tests a new inhaled medication (given through a device you breathe in) for adults with asthma. It is designed to reduce inflammation and improve breathing, and may help people who have not found relief with standard daily inhalers.
This trial tests whether a new inhaler (CHF5993) works as well as the current standard for adults with mild to moderate asthma. It compares how well the medicine controls asthma and opens airways.
This Phase 3 study compares a new inhaler (QMF149: indacaterol plus mometasone) against budesonide to see which works better and is safe for children ages 6 to under 12 with asthma. You may be able to join if your child is already on a stable low-dose steroid inhaler and still has symptoms.
This study tests an investigational medicine called PF-07275315 for people with moderate-to-severe asthma that is not well controlled with current treatments. The goal is to see if it can reduce asthma attacks and improve breathing.
This trial tests whether a new combination inhaler works as well as a commonly used one for teenagers with asthma that is not well controlled. It aims to find a safe and effective treatment option for adolescents.
Hear when a new Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.